ArticleDrug design, development and therapy2020

Pranlukast Antagonizes CD49f and Reduces Stemness in Triple-Negative Breast Cancer Cells.

Inés Velázquez-Quesada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.